In the context of loss of humoral tolerance against LEDGF/p75, we, therefore, aimed to investigate the occurrence of autoAbs to this oncogenic and survival antigen in serum samples from cancer patients as reported elsewhere [1,2,10]. This evidence concerns the gene PSIP1 and cancer.